This business information is not released now.


Back
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.


YGSRS Corporation
【Field/Business】
Drug discovery support/Contract service
Environment/Energy
Others
last update:2017/8/6
Profile

Delegates :
Henry Aoki


Incorporated :
April  8 , 2003

Paid in Capital :
10 Million yen  

Employees :
3 人

Address :
6 Ledge Rock Way, Unit 9, Acton, MA USA TOKYO
〒01720-6535

TEL/FAX :
978-742-9830 / 978-742-9830

URL:
http://www.ygsrs.com

Attachment :

Mission/Background :
Henry Aoki is an engineer with long technical development background. Using the technology he developed, extraction and solidification process, to restore health and maintain health of human being is our mission. We strive to create multiple nature based bioactive substances one after another, and we aim to extend its use in wide range of field.

Technology & Business
The technology, extraction and solidification process, is able to extract from various food material only the bioactive ingredient that was not possible to extract previously and make a solid form. That solidified bioactive ingredient is identified, and there will be discovery of new substance that is highly bioactive with anti-cancer, anti-inflammatory property. In pharmaceutical development, it has been long said that extraction, separation, and purification of bioactive ingredient is very difficult and time consuming. This technology is able to achieve that goal with ease in short time and low cost. It will be tremendous streamlining.To build up pipeline of many new pharmaceutical candidate is possible.
Peptide that will be discovered using this technology will have short sequence and high safety

Products & Service
Products & Service Name
Stage
Outline
Milestone
YGSRS peptide discovered from coffee beans
Preclinical
Anti-cancer, anti-inflammatory activity, low toxicity, patented. Scientific paper published.
License out as pharmaceutical candidate, functional food material.
GL3343, GL3393 New pharmaceutical candidate from soybean developed by Honda Trading Corp.
Discovery
Prospect of discovery of substance with anti-cancer, anti-inflammatory activity as drug candidate
Invite collaborative research, partnership
BD-305 New substance from a food material
Discovery
Prospect of discovery of substance with anti-cancer, anti-inflammatory activity as drug candidate
Invite collaborative research, partnership








Highlights
YGSRS peptide was discovered from coffee beans and patented. Highly bioactive. At 10mcg/kg wt., it exhibited 100% inhibition rate in Sarcoma and Inflammation. Scientific paper has been published in "Immunopharmacology and Immunotoxicology" in Great Britain.

Xanthone Derivative was discovered from mung bean and patented. Highly bioactive. At 10mcg/kg wt., it exhibited 100% inhibition rate in Sarcoma and Inflammation.

Hot news

Alliance strategy
Invite companies for collaborative research/partnership in discovering new drug candidate from soybean developed by Honda Trading Corporation using our technology.
Invite companies for collaborative research or partnership in discovering new drug candidate from various food material using our technology.


 
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.